We want to connect, learn from and work with you.
You can now submit your work for the EBMT-EHA 6th European CAR T-cell Meeting taking place on 15-17 February in Valencia, Spain.
Abstract and case report submissions are open until December 4, 2023.
The meeting hosts the 4th Emerging Investigators EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2024. Submitters under 40 years old at the time of the submission is sent, can apply for this award and the Scientific Programme Committee will select 3 winners. Winners will receive €10,000 and the opportunity to present their work on Day 1.
Both physicians and nurses are encouraged to submit their work. See how to submit and browse through the topics list and guidelines on the meeting website below.
The new EBMT Registry was officially launched on the 24th of August 2023. This is a remarkable achievement reflecting several years of dedicated teamwork. This innovative platform replaces ProMISe and Castor, streamlining our data management practices for a more cohesive user experience.
The purpose of the EBMT Registry remains clear: to provide a pool of data to EBMT members to conduct studies, assess epidemiological trends, and ultimately improve patients’ lives. Currently, not all functionalities are present, but we are working hard to successively add additional features. In addition, we will continue migrating the remaining data from the ProMISe database throughout the remainder of 2023 and into 2024. We will keep you updated on all aspects of this process.
It’s important to highlight that terminology updates have been implemented. MED-A is now referred to as the Core Dataset, and while the launch of the Extended Dataset (previously MED-B) is planned for 2024, preparations are well underway.
Guidance to the Implementation and operational management of marketed CAR T-cell therapy – by the GoCART Coalition Pharmacist Working Group
The GoCART Coalition is delighted to announce that its Pharmacist Working Group has published a guidance document on the Implementation and operational management of marketed CAR T-cell therapy.
You can find the article below in Bone Marrow Transplant.
A guide to the collection of T-cells by apheresis for ATMP manufacturing—recommendations of the GoCART coalition apheresis working group
The GoCART Coalition is proud to announce that, thanks to our experts in our apheresis working group, we have been able to build a set of recommendations for the field of Immune Effector Cells (IEC) based innovative therapies.